Loading
ผศ. อภิญญา  จุ๊สกุล

ผศ. อภิญญา จุ๊สกุล

คณะเทคนิคการแพทย์,
มหาวิทยาลัยขอนแก่น
37052311700: H-INDEX 15

บทความ

TCI อ้างอิงจาก http://www.tci-thaijo.org/

0

SCOPUS

0

PUBMED

0

ISI

0

TCI

Title Author Year SCOPUS PUBMED ISI TCI
1. Mechanisms of oxysterol-induced carcinogenesis. Jusakul, A.
Yongvanit, P.
Loilome, W.
Namwat, N.
2011
2. Expression of oxysterol binding protein isoforms in opisthorchiasis-associated cholangiocarcinoma: A potential molecular marker for tumor metastasis Loilome, W
Wechagama, P
Namwat, N
Jusakul, A
Sripa, B
Miwa, M
Kuver, R
Yongvanit, P
2012
3. Identification of Biliary Bile Acids in Patients with Benign Biliary Diseases, Hepatocellular Carcinoma and Cholangiocarcinoma Jusakul, A
Khuntikeo, N
Haigh, WG
Kuver, R
Ioannou, GN
Loilome, W
Namwat, N
Bhudhisawasdi, V
Pugkhem, A
Pairojkul, C
Yongvanit, P
2012
4. Liver fluke-induced hepatic oxysterols stimulate DNA damage and apoptosis in cultured human cholangiocytes Jusakul, A.
Loilome, W.
Namwat, N.
Dechakhamphu, S.
Sukontawarin, P.
Pinlaor, S.
Lee, S.P.
Yongvanit, P.
2012
5. Anti-apoptotic phenotypes of cholestan-3 beta,5 alpha,6 beta-triol-resistant human cholangiocytes: Characteristics contributing to the genesis of cholangiocarcinoma Jusakul, A.
Loilome, W.
Namwat, N.
Techasen, A.
Ioannou, G.N.
Yongvanit, P.
2013
6. Exome sequencing identifies distinct mutational patterns in liver fluke-related and non-infection-related bile duct cancers Chan-On, W
Nairismägi, ML
Ong, CK
Lim, WK
Dima, S
Pairojkul, C
Lim, KH
McPherson, JR
Cutcutache, I
Heng, HL
Ooi, L
Chung, A
Chow, P
Cheow, PC
Lee, SY
Choo, SP
Tan, IB
Duda, D
Nastase, A
Myint, SS
Wong, BH
Gan, A
Rajasegaran, V
Ng, CC
Nagarajan, S
Jusakul, A
Zhang, S
Vohra, P
Yu, W
Huang, D
Sithithaworn, P
Yongvanit, P
Wongkham, S
Khuntikeo, N
Bhudhisawasdi, V
Popescu, I
Rozen, SG
Tan, P
Teh, BT
2013
7. Association of CYP39A1, RUNX2 and oxidized alpha-1 antitrypsin expression in relation to cholangiocarcinoma progression. Chakkaphan Khenjanta
Raynoo Thanan
Apinya Jusakul
Anchalee Techasen
Wassana Jamnongkan
Nisana Namwat
Watcharin Loilome
Chawalit Pairojkul
Puangrat Yongvanit
2014
8. Genetics of Opisthorchis viverrini-related cholangiocarcinoma. Apinya Jusakul
Sarinya Kongpetch
Bin Tean Teh
2015
9. Pathogenesis of cholangiocarcinoma: From genetics to signalling pathways Sarinya Kongpetch
Apinya Jusakul
Choon Kiat Ong
Weng Khong Lim
Steven G. Rozen
Patrick Tan
Bin Tean Teh
2015
10. Tissue Microbiome Profiling Identifies an Enrichment of Specific Enteric Bacteria in Opisthorchis viverrini Associated Cholangiocarcinoma Kern Rei Chng
Sock Hoai Chan
Amanda Hui Qi Ng
Chenhao Li
Apinya Jusakul
Denis Bertrand
Andreas Wilm
Su Pin Choo
Damien Meng Yew Tan
Kiat Hon Lim
Roy Soetinko
Choon Kiat Ong
Dan G. Duda
Simona Dima
Irinel Popescu
Chaisiri Wongkham
Zhu Feng
Khay Guan Yeoh
Bin Tean Teh
Puangrat Yongvanit
Sopit Wongkham
Vajaraphongsa Bhudhisawasd
Narong Khuntikeo
Patrick Tan
Chawalit Pairojkul
Joanne Ngeow
Niranjan Nagarajan
2016
11. Establishment of cholangiocarcinoma cell lines from patients in the endemic area of liver fluke infection in Thailand Senggunprai, L.
Namwat, N.
Kongpetch, S.
Chamgramol, Y.
Loilome, W.
Khansaard, W.
Jusakul, A.
Prawan, A.
Pairojkul, C.
Yongvanit, P.
Kukongviriyapan, V.
2017
12. Whole-Genome and Epigenomic Landscapes of Etiologically Distinct Subtypes of Cholangiocarcinoma. Jusakul, A.
Cutcutache, I.
Kongpetch, S.
Myint, S.S.
Thanan, R.
Ng, C.C.Y.
Rajasegaran, V.
McPherson, J.R.
Khuntikeo, N.
Bhudhisawasdi, V.
Yongvanit, P.
Dima, S.O.L.
Shibata, T.
Pairojkul, C.
2017
13. TGF- beta 1: A Potential EMT-Biomarker for prediction of cholangiocarcinoma Phongsaran Kimawaha
Apinya Jusakul
Puangrat Yongvanit
Watcharin Loilome
Nisana Namwat
Narong Khuntikeo
Anchalee Techasen
2018
14. Whole-Genome and Epigenomic Landscapes of Etiologically Distinct Subtypes of Cholangiocarcinoma Apinya Jusakul
Ioana Cutcutache
Chern Han Yong
Jing Quan Lim
Mi Ni Huang
Nisha Padmanabhan
Vishwa Nellore
Sarinya Kongpetch
Alvin Wei Tian Ng
Ley Moy Ng
Su Pin Choo
Swe Swe Myint
Raynoo Thanan
Sanjanaa Nagarajan
Weng Khong Lim
Cedric Chuan Young Ng
Arnoud Boot
Mo Liu
Choon Kiat Ong
Vikneswari Rajasegaran
Stefanus Lie
Alvin Soon Tiong Lim
Tse Hui Lim
Jing Tan
Jia Liang Loh
John R. McPherson
Narong Khuntikeo
Vajaraphongsa Bhudhisawasdi
Puangrat Yongvanit
Sopit Wongkham
Yasushi Totoki
Hiromi Nakamura
Yasuhito Arai
Satoshi Yamasaki
Pierce Kah-Hoe Chow
Alexander Yaw Fui Chung
London Lucien Peng Jin Ooi
Kiat Hon Lim
Simona Dima
Dan G. Duda
Irinel Popescu
Philippe Broet
Sen-Yung Hsieh
Ming-Chin Yu
Aldo Scarpa
Jiaming Lai
Di-Xian Luo
Andre Lopes Carvalho
Andre Luiz Vettore
Hyungjin Rhee
Young Nyun Park
Ludmil B. Alexandrov
Raluca Gordan
Steven G. Rozen
Tatsuhiro Shibata
Chawalit Pairojkul
Bin Tean Teh
Patrick Tan
2018
15. Current omics-based biomarkers for cholangiocarcinoma. Kitti Intuyod
Napat Armartmuntree
Apinya Jusakul
Chadamas Sakonsinsiri
Raynoo Thanan
Somchai Pinlaor
2019
16. A combination of monosodium glutamate and high-fat and high-fructose diets increases the risk of kidney injury, gut dysbiosis and host-microbial co-metabolism Pongking, T
Haonon, O
Dangtakot, R
Onsurathum, S
Jusakul, A
Intuyod, K
Sangka, A
Anutrakulchai, S
Cha'on, U
Pinlaor, S
Pinlaor, P
2020
17. alterations and their clinical significance in cholangiocarcinoma. Namjan, A
Techasen, A
Loilome, W
Sa-Ngaimwibool, P
Jusakul, A
2020
18. ARID1A alterations and their clinical significance in cholangiocarcinoma Techasen, A.
Loilome, W.
Jusakul, A.
2020
19. Circulating TGF-beta 1 as the potential epithelial mesenchymal transition-biomarker for diagnosis of cholangiocarcinoma Jusakul, A.
Junsawang, P.
Loilome, W.
Khuntikeo, N.
Techasen, A.
2020
20. Enhancement of vitamin C on PMN function in healthy individuals Laongthip Ruknarong
Rujira Nonsa-ard
Nisa Chuangchot
Amonrat Jumnainsong
Naruemon Leelayuwat
Apinya Jusakul
Chanvit Leelayuwat
2020
21. Lack of Targetable FGFR2 Fusions in Endemic Fluke-Associated Cholangiocarcinoma Kongpetch, S
Jusakul, A
Lim, JQ
Ng, CCY
Chan, JY
Rajasegaran, V
Lim, TH
Lim, KH
Choo, SP
Dima, S
Popescu, I
Duda, DG
Kukongviriyapan, V
Khuntikeo, N
Pairojkul, C
Rozen, SG
Tan, P
Teh, BT
2020
22. Serum coiled-coil domain containing 25 protein as a potential screening/diagnostic biomarker for cholangiocarcinoma Chanakankun, R
Proungvitaya, T
Chua-On, D
Limpaiboon, T
Roytrakul, S
Jusakul, A
Titapun, A
Jarearnrat, A
Proungvitaya, S
2020
23. Arctigenin inhibits cholangiocarcinoma progression by regulating cell migration and cell viability via the N-cadherin and apoptosis pathway Janthamala, S
Jusakul, A
Kongpetch, S
Kimawaha, P
Klanrit, P
Loilome, W
Namwat, N
Techasen, A
2021
24. Concentration of urine samples improves sensitivity in detection of -specific IgG antibody in urine for diagnosis of strongyloidiasis. Chungkanchana, N
Sithithaworn, P
Worasith, C
Wongphutorn, P
Ruantip, S
Kopolrat, KY
Jusakul, A
Thanan, R
Duenngai, K
Sithithaworn, J
Techasen, A
2021
25. Diagnostic and Prognostic Value of Circulating Cell-Free DNA for Cholangiocarcinoma Preawwalee Wintachai
Jing Quan Lim
Anchalee Techasen
Worachart Lert-Itthiporn
Sarinya Kongpetch
Watcharin Loilome
Jarin Chindaprasirt
Attapol Titapun
Nisana Namwat
Narong Khuntikeo
Apinya Jusakul
2021
26. Diagnostic and prognostic value of circulating cell‐free dna for cholangiocarcinoma Wintachai, P.
Techasen, A.
Lert-Itthiporn, W.
Kongpetch, S.
Loilome, W.
Titapun, A.
Namwat, N.
Khuntikeo, N.
Jusakul, A.
2021
27. Establishment of a potential serum biomarker panel for the diagnosis and prognosis of cholangiocarcinoma using decision tree algorithms Phongsaran Kimawaha
Apinya Jusakul
Prem Junsawang
Raynoo Thanan
Attapol Titapun
Narong Khuntikeo
Anchalee Techasen
2021
28. Promoter hypermethylation of early B cell factor 1 (EBF1) is associated with cholangiocarcinoma progression Armartmuntree, N
Jusakul, A
Sakonsinsiri, C
Loilome, W
Pinlaor, S
Ungarreevittaya, P
Yong, CH
Techasen, A
Imtawil, K
Kraiklang, R
Suwannakul, N
Kaewlert, W
Chaiprasert, T
Thanan, R
Murata, M
2021
29. Vitamin C supplementation reduces expression of circulating miR-451a in subjects with poorly controlled type 2 diabetes mellitus and high oxidative stress Ruknarong, L
Boonthongkaew, C
Chuangchot, N
Jumnainsong, A
Leelayuwat, N
Jusakul, A
Gaudieri, S
Leelayuwat, C
2021
30. Concentration of Urine Samples Improves Sensitivity in Detection of Strongyloides-Specific IgG Antibody in Urine for Diagnosis of Strongyloidiasis Sithithaworn, P.
Worasith, C.
Wongphutorn, P.
Kopolrat, K.Y.
Jusakul, A.
Thanan, R.
Duenngai, K.
Sithithaworn, J.
Techasen, A.
2022
31. Inhibition of FGFR2 enhances chemosensitivity to gemcitabine in cholangiocarcinoma through the AKT/mTOR and EMT signaling pathways. Jaidee, R.
Kukongviriyapan, V.
Senggunprai, L.
Prawan, A.
Jusakul, A.
Laphanuwat, P.
Kongpetch, S.
2022
32. Prediction of Angiopoietin-like Protein 4-related Signaling Pathways in Cholangiocarcinoma Cells. Aung, T.M.
Silsirivanit, A.
Jusakul, A.
Chan-On, W.
Proungvitaya, T.
Roytrakul, S.
Proungvitaya, S.
2022
33. Serum Angiopoietin-Like Protein 4: A Potential Prognostic Biomarker for Prediction of Vascular Invasion and Lymph Node Metastasis in Cholangiocarcinoma Patients Aung, TM
Ciin, MN
Silsirivanit, A
Jusakul, A
Lert-Itthiporn, W
Proungvitaya, T
Roytrakul, S
Proungvitaya, S
2022
34. Therapeutic targeting of ARID1A and PI3K/AKT pathway alterations in cholangiocarcinoma. Techasen, A.
Kongpetch, S.
Namjan, A.
Loilome, W.
Chan-On, W.
Thanan, R.
Jusakul, A.
2022
Count 28 25 24 0

Title Authors Year Publication name Cited count
< 2017 2018 2019 2020 2021 2022 รวม
1. Mechanisms of oxysterol-induced carcinogenesis Jusakul, A.
Yongvanit, P.
Loilome, W.
Namwat, N.
2011 Lipids in Health and Disease
(10), pp.
2. Expression of oxysterol binding protein isoforms in opisthorchiasis-associated cholangiocarcinoma: A potential molecular marker for tumor metastasis Loilome, W.
Wechagama, P.
Namwat, N.
Jusakul, A.
Sripa, B.
Miwa, M.
Yongvanit, P.
2012 Parasitology International
1 (61), pp. 136-139
3. Identification of biliary bile acids in patients with benign biliary diseases, hepatocellular carcinoma and cholangiocarcinoma Jusakul, A.
Khuntikeo, N.
Ioannou, G.N.
Loilome, W.
Namwat, N.
Bhudhisawasdi, V.
Pugkhem, A.
Pairojkul, C.
Yongvanit, P.
2012 Asian Pacific Journal of Cancer Prevention
SUPPL.1 (13), pp. 77-82
4. Liver fluke-induced hepatic oxysterols stimulate DNA damage and apoptosis in cultured human cholangiocytes Jusakul, A.
Loilome, W.
Namwat, N.
Dechakhamphu, S.
Sukontawarin, P.
Pinlaor, S.
Lee, S.P.
Yongvanit, P.
2012 Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis
1-2 (731), pp. 48-57
5. Anti-apoptotic phenotypes of cholestan-3β,5α,6β-triol- resistant human cholangiocytes: Characteristics contributing to the genesis of cholangiocarcinoma Jusakul, A.
Loilome, W.
Namwat, N.
Techasen, A.
Ioannou, G.N.
Yongvanit, P.
2013 Journal of Steroid Biochemistry and Molecular Biology
(138), pp. 368-375
6. Exome sequencing identifies distinct mutational patterns in liver fluke-related and non-infection-related bile duct cancers Chan-On, W.
Dima, S.O.L.
Pairojkul, C.
Lim, K.
McPherson, J.R.
Cutcutache, I.
Heng, H.
Choo, S.
Tan, I.B.H.
Myint, S.S.
Wong, B.
Rajasegaran, V.
Ng, C.C.Y.
Jusakul, A.
Huang, D.
Sithithaworn, P.
Yongvanit, P.
Wongkham, S.
Khuntikeo, N.
Bhudhisawasdi, V.
2013 Nature Genetics
12 (45), pp. 1474-1478
7. Association of CYP39A1, RUNX2 and oxidized alpha-1 antitrypsin expression in relation to cholangiocarcinoma progression Khenjanta, C.
Thanan, R.
Jusakul, A.
Techasen, A.
Jamnongkan, W.
Namwat, N.
Loilome, W.
Pairojkul, C.
Yongvanit, P.
2014 Asian Pacific Journal of Cancer Prevention
23 (15), pp. 10187-10192
8. Genetics of Opisthorchis viverrini -related cholangiocarcinoma Jusakul, A.
Kongpetch, S.
2015 Current Opinion in Gastroenterology
3 (31), pp. 258-263
9. Pathogenesis of cholangiocarcinoma: From genetics to signalling pathways Kongpetch, S.
Jusakul, A.
Ong, C.
Lim, W.
2015 Best Practice and Research: Clinical Gastroenterology
2 (29), pp. 233-244
10. Tissue Microbiome Profiling Identifies an Enrichment of Specific Enteric Bacteria in Opisthorchis viverrini Associated Cholangiocarcinoma Jusakul, A.
Choo, S.
Lim, K.
Ong, C.
Dima, S.O.L.
Wongkham, C.
Yongvanit, P.
Wongkham, S.
Bhudhisawasdi, V.
Khuntikeo, N.
Pairojkul, C.
Nagarajan, N.S.
2016 EBioMedicine
(8), pp. 195-202
11. Establishment of cholangiocarcinoma cell lines from patients in the endemic area of liver fluke infection in Thailand Senggunprai, L.
Namwat, N.
Kongpetch, S.
Chamgramol, Y.
Loilome, W.
Khansaard, W.
Jusakul, A.
Prawan, A.
Pairojkul, C.
Yongvanit, P.
Kukongviriyapan, V.
2017 Tumor Biology
11 (39), pp.
12. Whole-genome and epigenomic landscapes of etiologically distinct subtypes of cholangiocarcinoma Jusakul, A.
Cutcutache, I.
Kongpetch, S.
Myint, S.S.
Thanan, R.
Ng, C.C.Y.
Rajasegaran, V.
McPherson, J.R.
Khuntikeo, N.
Bhudhisawasdi, V.
Yongvanit, P.
Dima, S.O.L.
Shibata, T.
Pairojkul, C.
2017 Cancer Discovery
10 (7), pp. 1116-1135
13. Current omics-based biomarkers for cholangiocarcinoma Intuyod, K.
Armartmuntree, N.
Jusakul, A.
Sakonsinsiri, C.
Thanan, R.
Pinlaor, S.
2019 Expert Review of Molecular Diagnostics
11 (19), pp. 997-1005
14. A combination of monosodium glutamate and high-fat and high-fructose diets increases the risk of kidney injury, gut dysbiosis and host-microbial co-metabolism Haonon, O.
Onsurathum, S.
Jusakul, A.
Intuyod, K.
Sangka, A.
Anutrakulchai, S.
Cha'on, U.
Pinlaor, S.
Pinlaor, P.
2020 PLoS ONE
4 (15), pp.
15. ARID1A alterations and their clinical significance in cholangiocarcinoma Techasen, A.
Loilome, W.
Jusakul, A.
2020 PeerJ
(8), pp.
16. Circulating TGF-β1 as the potential epithelial mesenchymal transition-biomarker for diagnosis of cholangiocarcinoma Jusakul, A.
Junsawang, P.
Loilome, W.
Khuntikeo, N.
Techasen, A.
2020 Journal of Gastrointestinal Oncology
2 (11), pp. 304-318
17. Lack of targetable FGFR2 fusions in endemic fluke-associated cholangiocarcinoma Kongpetch, S.
Jusakul, A.
Ng, C.C.Y.
Rajasegaran, V.
Dima, S.O.L.
Kukongviriyapan, V.
Khuntikeo, N.
Pairojkul, C.
2020 JCO Global Oncology
(6), pp. 628-638
18. Serum coiled-coil domain containing 25 protein as a potential screening/diagnostic biomarker for cholangiocarcinoma Proungvitaya, T.
Limpaiboon, T.
Jusakul, A.
Titapun, A.
Patrakitkomjorn, S.
2020 Oncology Letters
1 (19), pp. 930-942
19. Arctigenin inhibits cholangiocarcinoma progression by regulating cell migration and cell viability via the N-cadherin and apoptosis pathway Jusakul, A.
Kongpetch, S.
Kimawaha, P.
Klanrit, P.
Loilome, W.
Namwat, N.
Techasen, A.
2021 Naunyn-Schmiedeberg's Archives of Pharmacology
10 (394), pp. 2049-2059
20. Diagnostic and prognostic value of circulating cell‐free dna for cholangiocarcinoma Wintachai, P.
Techasen, A.
Lert-Itthiporn, W.
Kongpetch, S.
Loilome, W.
Titapun, A.
Namwat, N.
Khuntikeo, N.
Jusakul, A.
2021 Diagnostics
6 (11), pp.
21. Establishment of a potential serum biomarker panel for the diagnosis and prognosis of cholangiocarcinoma using decision tree algorithms Kimawaha, P.
Jusakul, A.
Junsawang, P.
Thanan, R.
Titapun, A.
Khuntikeo, N.
Techasen, A.
2021 Diagnostics
4 (11), pp.
22. Promoter hypermethylation of early B cell factor 1 (EBF1) is associated with cholangiocarcinoma progression Armartmuntree, N.
Jusakul, A.
Sakonsinsiri, C.
Loilome, W.
Pinlaor, S.
Ungarreevittaya, P.
Techasen, A.
Imtawil, K.J.
Kraiklang, R.
Suwannakul, N.
Thanan, R.
2021 Journal of Cancer
9 (12), pp. 2673-2686
23. Vitamin C supplementation reduces expression of circulating miR-451a in subjects with poorly controlled type 2 diabetes mellitus and high oxidative stress Jumnainsong, A.
Leelayuwat, N.
Jusakul, A.
Leelayuwat, C.
2021 PeerJ
(9), pp.
24. Concentration of Urine Samples Improves Sensitivity in Detection of Strongyloides-Specific IgG Antibody in Urine for Diagnosis of Strongyloidiasis Sithithaworn, P.
Worasith, C.
Wongphutorn, P.
Kopolrat, K.Y.
Jusakul, A.
Thanan, R.
Duenngai, K.
Sithithaworn, J.
Techasen, A.
2022 Journal of clinical microbiology
1 (60), pp. e0145421
25. Inhibition of FGFR2 enhances chemosensitivity to gemcitabine in cholangiocarcinoma through the AKT/mTOR and EMT signaling pathways Jaidee, R.
Kukongviriyapan, V.
Senggunprai, L.
Prawan, A.
Jusakul, A.
Laphanuwat, P.
Kongpetch, S.
2022 Life Sciences
(296), pp.
26. Prediction of Angiopoietin-like Protein 4-related Signaling Pathways in Cholangiocarcinoma Cells Aung, T.M.
Silsirivanit, A.
Jusakul, A.
Chan-On, W.
Proungvitaya, T.
Roytrakul, S.
Proungvitaya, S.
2022 Cancer Genomics and Proteomics
4 (19), pp. 490-502
27. Serum Angiopoietin-Like Protein 4: A Potential Prognostic Biomarker for Prediction of Vascular Invasion and Lymph Node Metastasis in Cholangiocarcinoma Patients Silsirivanit, A.
Jusakul, A.
Lert-Itthiporn, W.
Proungvitaya, T.
Patrakitkomjorn, S.
2022 Frontiers in Public Health
(10), pp.
28. Therapeutic targeting of ARID1A and PI3K/AKT pathway alterations in cholangiocarcinoma Techasen, A.
Kongpetch, S.
Namjan, A.
Loilome, W.
Chan-On, W.
Thanan, R.
Jusakul, A.
2022 PeerJ
(10), pp.

Title Authors Year Journal title
1. Mechanisms of oxysterol-induced carcinogenesis. Jusakul, A
Yongvanit, P
Loilome, W
Namwat, N
Kuver, R
2011 Lipids in health and disease
(10), pp. 44
2. Liver fluke-induced hepatic oxysterols stimulate DNA damage and apoptosis in cultured human cholangiocytes. Jusakul, A
Loilome, W
Namwat, N
Haigh, WG
Kuver, R
Dechakhamphu, S
Sukontawarin, P
Pinlaor, S
Lee, SP
Yongvanit, P
2012 Mutation research
1 (731), pp. 48-57
3. Identification of biliary bile acids in patients with benign biliary diseases, hepatocellular carcinoma and cholangiocarcinoma. Jusakul, A
Khuntikeo, N
Haigh, WG
Kuver, R
Ioannou, GN
Loilome, W
Namwat, N
Bhudhisawasdi, V
Pugkhem, A
Pairojkul, C
Yongvanit, P
2012 Asian Pacific journal of cancer prevention : APJCP
(13), pp. 77-82
4. Expression of oxysterol binding protein isoforms in opisthorchiasis-associated cholangiocarcinoma: a potential molecular marker for tumor metastasis. Loilome, W
Wechagama, P
Namwat, N
Jusakul, A
Sripa, B
Miwa, M
Kuver, R
Yongvanit, P
2012 Parasitology international
1 (61), pp. 136-9
5. Exome sequencing identifies distinct mutational patterns in liver fluke-related and non-infection-related bile duct cancers. Chan-On, W
Nairismägi, ML
Ong, CK
Lim, WK
Dima, S
Pairojkul, C
Lim, KH
McPherson, JR
Cutcutache, I
Heng, HL
Ooi, L
Chung, A
Chow, P
Cheow, PC
Lee, SY
Choo, SP
Tan, IB
Duda, D
Nastase, A
Myint, SS
Wong, BH
Gan, A
Rajasegaran, V
Ng, CC
Nagarajan, S
Jusakul, A
Zhang, S
Vohra, P
Yu, W
Huang, D
Sithithaworn, P
Yongvanit, P
Wongkham, S
Khuntikeo, N
Bhudhisawasdi, V
Popescu, I
Rozen, SG
Tan, P
Teh, BT
2013 Nature genetics
12 (45), pp. 1474-8
6. Anti-apoptotic phenotypes of cholestan-3β,5α,6β-triol-resistant human cholangiocytes: characteristics contributing to the genesis of cholangiocarcinoma. Jusakul, A
Loilome, W
Namwat, N
Techasen, A
Kuver, R
Ioannou, GN
Savard, C
Haigh, WG
Yongvanit, P
2013 The Journal of steroid biochemistry and molecular biology
(138), pp. 368-75
7. Association of CYP39A1, RUNX2 and oxidized alpha-1 antitrypsin expression in relation to cholangiocarcinoma progression. Khenjanta, C
Thanan, R
Jusakul, A
Techasen, A
Jamnongkan, W
Namwat, N
Loilome, W
Pairojkul, C
Yongvanit, P
2014 Asian Pacific journal of cancer prevention : APJCP
23 (15), pp. 10187-92
8. Genetics of Opisthorchis viverrini-related cholangiocarcinoma. Jusakul, A
Kongpetch, S
Teh, BT
2015 Current opinion in gastroenterology
3 (31), pp. 258-63
9. Pathogenesis of cholangiocarcinoma: From genetics to signalling pathways. Kongpetch, S
Jusakul, A
Ong, CK
Lim, WK
Rozen, SG
Tan, P
Teh, BT
2015 Best practice & research. Clinical gastroenterology
2 (29), pp. 233-44
10. Tissue Microbiome Profiling Identifies an Enrichment of Specific Enteric Bacteria in Opisthorchis viverrini Associated Cholangiocarcinoma. Chng, KR
Chan, SH
Ng, AH
Li, C
Jusakul, A
Bertrand, D
Wilm, A
Choo, SP
Tan, DM
Lim, KH
Soetinko, R
Ong, CK
Duda, DG
Dima, S
Popescu, I
Wongkham, C
Feng, Z
Yeoh, KG
Teh, BT
Yongvanit, P
Wongkham, S
Bhudhisawasdi, V
Khuntikeo, N
Tan, P
Pairojkul, C
Ngeow, J
Nagarajan, N
2016 EBioMedicine
(8), pp. 195-202
11. Whole-Genome and Epigenomic Landscapes of Etiologically Distinct Subtypes of Cholangiocarcinoma. Jusakul, A
Cutcutache, I
Yong, CH
Lim, JQ
Huang, MN
Padmanabhan, N
Nellore, V
Kongpetch, S
Ng, AWT
Ng, LM
Choo, SP
Myint, SS
Thanan, R
Nagarajan, S
Lim, WK
Ng, CCY
Boot, A
Liu, M
Ong, CK
Rajasegaran, V
Lie, S
Lim, AST
Lim, TH
Tan, J
Loh, JL
McPherson, JR
Khuntikeo, N
Bhudhisawasdi, V
Yongvanit, P
Wongkham, S
Totoki, Y
Nakamura, H
Arai, Y
Yamasaki, S
Chow, PK
Chung, AYF
Ooi, LLPJ
Lim, KH
Dima, S
Duda, DG
Popescu, I
Broet, P
Hsieh, SY
Yu, MC
Scarpa, A
Lai, J
Luo, DX
Carvalho, AL
Vettore, AL
Rhee, H
Park, YN
Alexandrov, LB
Gordân, R
Rozen, SG
Shibata, T
Pairojkul, C
Teh, BT
Tan, P
2017 Cancer discovery
10 (7), pp. 1116-1135
12. Current omics-based biomarkers for cholangiocarcinoma. Intuyod, K
Armartmuntree, N
Jusakul, A
Sakonsinsiri, C
Thanan, R
Pinlaor, S
2019 Expert review of molecular diagnostics
(), pp. 1-9
13. Circulating TGF-β1 as the potential epithelial mesenchymal transition-biomarker for diagnosis of cholangiocarcinoma. Kimawaha, P
Jusakul, A
Junsawang, P
Loilome, W
Khuntikeo, N
Techasen, A
2020 Journal of gastrointestinal oncology
2 (11), pp. 304-318
14. alterations and their clinical significance in cholangiocarcinoma. Namjan, A
Techasen, A
Loilome, W
Sa-Ngaimwibool, P
Jusakul, A
2020 PeerJ
(8), pp. e10464
15. Serum coiled-coil domain containing 25 protein as a potential screening/diagnostic biomarker for cholangiocarcinoma. Chanakankun, R
Proungvitaya, T
Chua-On, D
Limpaiboon, T
Roytrakul, S
Jusakul, A
Titapun, A
Jarearnrat, A
Proungvitaya, S
2020 Oncology letters
1 (19), pp. 930-942
16. A combination of monosodium glutamate and high-fat and high-fructose diets increases the risk of kidney injury, gut dysbiosis and host-microbial co-metabolism. Pongking, T
Haonon, O
Dangtakot, R
Onsurathum, S
Jusakul, A
Intuyod, K
Sangka, A
Anutrakulchai, S
Cha'on, U
Pinlaor, S
Pinlaor, P
2020 PloS one
4 (15), pp. e0231237
17. Lack of Targetable FGFR2 Fusions in Endemic Fluke-Associated Cholangiocarcinoma. Kongpetch, S
Jusakul, A
Lim, JQ
Ng, CCY
Chan, JY
Rajasegaran, V
Lim, TH
Lim, KH
Choo, SP
Dima, S
Popescu, I
Duda, DG
Kukongviriyapan, V
Khuntikeo, N
Pairojkul, C
Rozen, SG
Tan, P
Teh, BT
2020 JCO global oncology
(6), pp. 628-638
18. Vitamin C supplementation reduces expression of circulating miR-451a in subjects with poorly controlled type 2 diabetes mellitus and high oxidative stress. Ruknarong, L
Boonthongkaew, C
Chuangchot, N
Jumnainsong, A
Leelayuwat, N
Jusakul, A
Gaudieri, S
Leelayuwat, C
2021 PeerJ
(9), pp. e10776
19. Concentration of urine samples improves sensitivity in detection of -specific IgG antibody in urine for diagnosis of strongyloidiasis. Chungkanchana, N
Sithithaworn, P
Worasith, C
Wongphutorn, P
Ruantip, S
Kopolrat, KY
Jusakul, A
Thanan, R
Duenngai, K
Sithithaworn, J
Techasen, A
2021 Journal of clinical microbiology
(), pp. JCM0145421
20. Promoter hypermethylation of early B cell factor 1 (EBF1) is associated with cholangiocarcinoma progression. Armartmuntree, N
Jusakul, A
Sakonsinsiri, C
Loilome, W
Pinlaor, S
Ungarreevittaya, P
Yong, CH
Techasen, A
Imtawil, K
Kraiklang, R
Suwannakul, N
Kaewlert, W
Chaiprasert, T
Thanan, R
Murata, M
2021 Journal of Cancer
9 (12), pp. 2673-2686
21. Arctigenin inhibits cholangiocarcinoma progression by regulating cell migration and cell viability via the N-cadherin and apoptosis pathway. Janthamala, S
Jusakul, A
Kongpetch, S
Kimawaha, P
Klanrit, P
Loilome, W
Namwat, N
Techasen, A
2021 Naunyn-Schmiedeberg's archives of pharmacology
10 (394), pp. 2049-2059
22. Serum Angiopoietin-Like Protein 4: A Potential Prognostic Biomarker for Prediction of Vascular Invasion and Lymph Node Metastasis in Cholangiocarcinoma Patients. Aung, TM
Ciin, MN
Silsirivanit, A
Jusakul, A
Lert-Itthiporn, W
Proungvitaya, T
Roytrakul, S
Proungvitaya, S
2022 Frontiers in public health
(10), pp. 836985
23. Inhibition of FGFR2 enhances chemosensitivity to gemcitabine in cholangiocarcinoma through the AKT/mTOR and EMT signaling pathways. Jaidee, R
Kukongviriyapan, V
Senggunprai, L
Prawan, A
Jusakul, A
Laphanuwat, P
Kongpetch, S
2022 Life sciences
(), pp. 120427
24. Therapeutic targeting of ARID1A and PI3K/AKT pathway alterations in cholangiocarcinoma. Tessiri, S
Techasen, A
Kongpetch, S
Namjan, A
Loilome, W
Chan-On, W
Thanan, R
Jusakul, A
2022 PeerJ
(10), pp. e12750
25. Prediction of Angiopoietin-like Protein 4-related Signaling Pathways in Cholangiocarcinoma Cells. Aung, TM
Silsirivanit, A
Jusakul, A
Chan-On, W
Proungvitaya, T
Roytrakul, S
Proungvitaya, S
2022 Cancer genomics & proteomics
4 (19), pp. 490-502

Title Authors Year Journal title Cited count
< 2017 2018 2019 2020 2021 2022 รวม
1. Mechanisms of oxysterol-induced carcinogenesis Apinya Jusakul
Puangrat Yongvanit
Watcharin Loilome
Nisana Namwat
Rahul Kuver
2011 LIPIDS IN HEALTH AND DISEASE
(10.0), pp.
58 0 0 0 0 0 58
2. Expression of oxysterol binding protein isoforms in opisthorchiasis-associated cholangiocarcinoma: A potential molecular marker for tumor metastasis Watcharin Loilome
Pairoj Wechagama
Nisana Namwat
Apinya Jusakul
Banchob Sripa
Masanao Miwa
Rahul Kuver
Puangrat Yongvanit
2012 PARASITOLOGY INTERNATIONAL
1.0 (61.0), pp. 136.0-139.0
23 0 0 0 0 0 23
3. Identification of Biliary Bile Acids in Patients with Benign Biliary Diseases, Hepatocellular Carcinoma and Cholangiocarcinoma Apinya Jusakul
Narong Khuntikeo
W. Geoffrey Haigh
Rahul Kuver
George N. Ioannou
Watcharin Loilome
Nisana Namwat
Vajarabhongsa Bhudhisawasdi
Ake Pugkhem
Chawalit Pairojkul
Puangrat Yongvanit
2012 ASIAN PACIFIC JOURNAL OF CANCER PREVENTION
(13.0), pp. 77.0-82.0
8 0 0 0 0 0 8
4. Liver fluke-induced hepatic oxysterols stimulate DNA damage and apoptosis in cultured human cholangiocytes Apinya Jusakul
Watcharin Loilome
Nisana Namwat
W. Geoffrey Haigh
Rahul Kuver
Somkid Dechakhamphu
Pradit Sukontawarin
Somchai Pinlaor
Sum P. Lee
Puangrat Yongvanit
2012 MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS
1-2 (731.0), pp. 48.0-57.0
34 0 0 0 0 0 34
5. Anti-apoptotic phenotypes of cholestan-3 beta,5 alpha,6 beta-triol-resistant human cholangiocytes: Characteristics contributing to the genesis of cholangiocarcinoma Apinya Jusakul
Watcharin Loilome
Nisana Namwat
Anchalee Techasen
Rahul Kuver
George N. Ioannou
Christopher Savard
W. Geoffrey Haigh
Puangrat Yongvanit
2013 JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY
(138.0), pp. 368.0-375.0
14 0 0 0 0 0 14
6. Exome sequencing identifies distinct mutational patterns in liver fluke-related and non-infection-related bile duct cancers Waraporn Chan-on
Maarja-Liisa Nairismaegi
Choon Kiat Ong
Weng Khong Lim
Simona Dima
Chawalit Pairojkul
Kiat Hon Lim
John R. McPherson
Ioana Cutcutache
Hong Lee Heng
London Ooi
Alexander Chung
Pierce Chow
Peng Chung Cheow
Ser Yee Lee
Su Pin Choo
Iain Bee Huat Tan
Dan Duda
Anca Nastase
Swe Swe Myint
Bernice Huimin Wong
Anna Gan
Vikneswari Rajasegaran
Cedric Chuan Young Ng
Sanjanaa Nagarajan
Apinya Jusakul
Shenli Zhang
Priya Vohra
Willie Yu
DaChuan Huang
Paiboon Sithithaworn
Puangrat Yongvanit
Sopit Wongkham
Narong Khuntikeo
Vajaraphongsa Bhudhisawasdi
Irinel Popescu
Steven G. Rozen
Patrick Tan
Bin Tean Teh
2013 NATURE GENETICS
12.0 (45.0), pp. 1474.0-U100
247 0 0 0 0 0 247
7. Association of CYP39A1, RUNX2 and Oxidized Alpha-1 Antitrypsin Expression in Relation to Cholangiocarcinoma Progression Chakkaphan Khenjanta
Raynoo Thanan
Apinya Jusakul
Anchalee Techasen
Wassana Jamnongkan
Nisana Namwat
Watcharin Loilome
Chawalit Pairojkul
Puangrat Yongvanit
2014 ASIAN PACIFIC JOURNAL OF CANCER PREVENTION
23.0 (15.0), pp. 10187.0-10192.0
12 0 0 0 0 0 12
8. Genetics of Opisthorchis viverrini-related cholangiocarcinoma Apinya Jusakul
Sarinya Kongpetch
Bin Tean Teh
2015 CURRENT OPINION IN GASTROENTEROLOGY
3.0 (31.0), pp. 258.0-263.0
38 0 0 0 0 0 38
9. Pathogenesis of cholangiocarcinoma: From genetics to signalling pathways Sarinya Kongpetch
Apinya Jusakul
Choon Kiat Ong
Weng Khong Lim
Steven G. Rozen
Patrick Tan
Bin Tean Teh
2015 BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY
2.0 (29.0), pp. 233.0-244.0
36 0 0 0 0 0 36
10. Tissue Microbiome Profiling Identifies an Enrichment of Specific Enteric Bacteria in Opisthorchis viverrini Associated Cholangiocarcinoma Kern Rei Chng
Sock Hoai Chan
Amanda Hui Qi Ng
Chenhao Li
Apinya Jusakul
Denis Bertrand
Andreas Wilm
Su Pin Choo
Damien Meng Yew Tan
Kiat Hon Lim
Roy Soetinko
Choon Kiat Ong
Dan G. Duda
Simona Dima
Irinel Popescu
Chaisiri Wongkham
Zhu Feng
Khay Guan Yeoh
Bin Tean Teh
Puangrat Yongvanit
Sopit Wongkham
Vajaraphongsa Bhudhisawasd
Narong Khuntikeo
Patrick Tan
Chawalit Pairojkul
Joanne Ngeow
Niranjan Nagarajan
2016 EBIOMEDICINE
(8.0), pp. 195.0-202.0
53 0 0 0 0 0 53
11. TGF- beta 1: A Potential EMT-Biomarker for prediction of cholangiocarcinoma Phongsaran Kimawaha
Apinya Jusakul
Puangrat Yongvanit
Watcharin Loilome
Nisana Namwat
Narong Khuntikeo
Anchalee Techasen
2018 CANCER SCIENCE
(109.0), pp. 956.0-956.0
0 0 0 0 0 0 0
12. Whole-Genome and Epigenomic Landscapes of Etiologically Distinct Subtypes of Cholangiocarcinoma Apinya Jusakul
Ioana Cutcutache
Chern Han Yong
Jing Quan Lim
Mi Ni Huang
Nisha Padmanabhan
Vishwa Nellore
Sarinya Kongpetch
Alvin Wei Tian Ng
Ley Moy Ng
Su Pin Choo
Swe Swe Myint
Raynoo Thanan
Sanjanaa Nagarajan
Weng Khong Lim
Cedric Chuan Young Ng
Arnoud Boot
Mo Liu
Choon Kiat Ong
Vikneswari Rajasegaran
Stefanus Lie
Alvin Soon Tiong Lim
Tse Hui Lim
Jing Tan
Jia Liang Loh
John R. McPherson
Narong Khuntikeo
Vajaraphongsa Bhudhisawasdi
Puangrat Yongvanit
Sopit Wongkham
Yasushi Totoki
Hiromi Nakamura
Yasuhito Arai
Satoshi Yamasaki
Pierce Kah-Hoe Chow
Alexander Yaw Fui Chung
London Lucien Peng Jin Ooi
Kiat Hon Lim
Simona Dima
Dan G. Duda
Irinel Popescu
Philippe Broet
Sen-Yung Hsieh
Ming-Chin Yu
Aldo Scarpa
Jiaming Lai
Di-Xian Luo
Andre Lopes Carvalho
Andre Luiz Vettore
Hyungjin Rhee
Young Nyun Park
Ludmil B. Alexandrov
Raluca Gordan
Steven G. Rozen
Tatsuhiro Shibata
Chawalit Pairojkul
Bin Tean Teh
Patrick Tan
2018 CANCER SCIENCE
(109.0), pp. 720.0-720.0
243 0 0 0 0 0 243
13. Current omics-based biomarkers for cholangiocarcinoma Kitti Intuyod
Napat Armartmuntree
Apinya Jusakul
Chadamas Sakonsinsiri
Raynoo Thanan
Somchai Pinlaor
2019 EXPERT REVIEW OF MOLECULAR DIAGNOSTICS
11.0 (19.0), pp. 997.0-1005.0
0 0 0 0 0 0 0
14. A combination of monosodium glutamate and high-fat and high-fructose diets increases the risk of kidney injury, gut dysbiosis and host-microbial co-metabolism Thatsanapong Pongking
Ornuma Haonon
Rungtiwa Dangtakot
Sudarat Onsurathum
Apinya Jusakul
Kitti Intuyod
Arunnee Sangka
Sirirat Anutrakulchai
Ubon Cha'on
Somchai Pinlaor
Porntip Pinlaor
2020 PLOS ONE
4.0 (15.0), pp.
5 0 0 0 0 0 5
15. ARID1A alterations and their clinical significance in cholangiocarcinoma Achira Namjan
Anchalee Techasen
Watcharin Loilome
Prakasit Sa-ngairnwibool
Apinya Jusakul
2020 PEERJ
(8.0), pp.
1 0 0 0 0 0 1
16. Circulating TGF-beta 1 as the potential epithelial mesenchymal transition-biomarker for diagnosis of cholangiocarcinoma Phongsaran Kimawaha
Apinya Jusakul
Prem Junsawang
Watcharin Loilome
Narong Khuntikeo
Anchalee Techasen
2020 JOURNAL OF GASTROINTESTINAL ONCOLOGY
2.0 (11.0), pp. 304.0-318.0
3 0 0 0 0 0 3
17. Enhancement of vitamin C on PMN function in healthy individuals Laongthip Ruknarong
Rujira Nonsa-ard
Nisa Chuangchot
Amonrat Jumnainsong
Naruemon Leelayuwat
Apinya Jusakul
Chanvit Leelayuwat
2020 JOURNAL OF IMMUNOLOGY
1.0 (204.0), pp.
0 0 0 0 0 0 0
18. Lack of Targetable FGFR2 Fusions in Endemic Fluke-Associated Cholangiocarcinoma Sarinya Kongpetch
Apinya Jusakul
Jing Quan Lim
Cedric Chuan Young Ng
Jason Yongsheng Chan
Vikneswari Rajasegaran
Tse Hui Lim
Kiat Hon Lim
Su Pin Choo
Simona Dima
Irinel Popescu
Dan G. Duda
Veerapol Kukongviriyapan
Narong Khuntikeo
Chawalit Pairojkul
Steven G. Rozen
Patrick Tan
Bin Tean Teh
2020 JCO GLOBAL ONCOLOGY
(6.0), pp. 628.0-638.0
7 0 0 0 0 0 7
19. Serum coiled-coil domain containing 25 protein as a potential screening/diagnostic biomarker for cholangiocarcinoma Ravinnipa Chanakankun
Tanakorn Proungvitaya
Daraporn Chua-On
Temduang Limpaiboon
Sittiruk Roytrakul
Apinya Jusakul
Attapol Titapun
Apiwat Jarearnrat
Siriporn Proungvitaya
2020 ONCOLOGY LETTERS
1.0 (19.0), pp. 930.0-942.0
2 0 0 0 0 0 2
20. Arctigenin inhibits cholangiocarcinoma progression by regulating cell migration and cell viability via the N-cadherin and apoptosis pathway Sutthiwan Janthamala
Apinya Jusakul
Sarinya Kongpetch
Phongsaran Kimawaha
Poramate Klanrit
Watcharin Loilome
Nisana Namwat
Anchalee Techasen
2021 NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY
10.0 (394.0), pp. 2049.0-2059.0
0 0 0 0 0 0 0
21. Diagnostic and Prognostic Value of Circulating Cell-Free DNA for Cholangiocarcinoma Preawwalee Wintachai
Jing Quan Lim
Anchalee Techasen
Worachart Lert-Itthiporn
Sarinya Kongpetch
Watcharin Loilome
Jarin Chindaprasirt
Attapol Titapun
Nisana Namwat
Narong Khuntikeo
Apinya Jusakul
2021 DIAGNOSTICS
6.0 (11.0), pp.
0 0 0 0 0 0 0
22. Establishment of a Potential Serum Biomarker Panel for the Diagnosis and Prognosis of Cholangiocarcinoma Using Decision Tree Algorithms Phongsaran Kimawaha
Apinya Jusakul
Prem Junsawang
Raynoo Thanan
Attapol Titapun
Narong Khuntikeo
Anchalee Techasen
2021 DIAGNOSTICS
4.0 (11.0), pp.
1 0 0 0 0 0 1
23. Promoter hypermethylation of early B cell factor 1 (EBF1) is associated with cholangiocarcinoma progression Napat Armartmuntree
Apinya Jusakul
Chadamas Sakonsinsiri
Watcharin Loilome
Somchai Pinlaor
Piti Ungarreevittaya
Chern Han Yong
Anchalee Techasen
Kanokwan Imtawil
Ratthaphol Kraiklang
Nattawan Suwannakul
Waleeporn Kaewlert
Timpika Chaiprasert
Raynoo Thanan
Mariko Murata
2021 JOURNAL OF CANCER
9.0 (12.0), pp. 2673.0-2686.0
0 0 0 0 0 0 0
24. Vitamin C supplementation reduces expression of circulating miR-451a in subjects with poorly controlled type 2 diabetes mellitus and high oxidative stress Laongthip Ruknarong
Chongchira Boonthongkaew
Nisa Chuangchot
Amonrat Jumnainsong
Naruemon Leelayuwat
Apinya Jusakul
Silvana Gaudieri
Chanvit Leelayuwat
2021 PEERJ
(9.0), pp.
3 0 0 0 0 0 3

Title Authors Year Journal title

ชื่อโครงการ Authors ประเภทโครงการ ปีงบประมาณ ทุนวิจับ

0.013021707534790039